178 related articles for article (PubMed ID: 8103656)
1. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis.
Mukae H; Hirota M; Kohno S; Komori K; Fukushima K; Hiratani K; Kadota J; Hara K
Am Rev Respir Dis; 1993 Sep; 148(3):744-51. PubMed ID: 8103656
[TBL] [Abstract][Full Text] [Related]
2. [Tumor associated carbohydrate antigens in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
Mukae H; Sakito O; Oda H; Senju R; Fukushima K; Hiratani K; Kadota J; Komori K; Kohno S; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30(12):2075-81. PubMed ID: 1289627
[TBL] [Abstract][Full Text] [Related]
3. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.
Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K
Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of serum sialyl Lewis X-i (SLX) in diffuse panbronchiolitis].
Noguchi M; Nakatani T; Chohnabayashi N; Nakamori Y; Nakata K; Matsushita H; Tanimoto H
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):317-25. PubMed ID: 2575680
[TBL] [Abstract][Full Text] [Related]
5. [A clinical study of the long-term therapeutic effects of low-dose erythromycin in diffuse panbronchiolitis--with special reference to changes in tumor-associated carbohydrate antigens in serum].
Mukae H; Komori K; Morikawa N; Sakito O; Oda H; Senju R; Fukushima K; Hiratani K; Kadota J; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):802-7. PubMed ID: 1352834
[TBL] [Abstract][Full Text] [Related]
6. [Association between diffuse panbronchiolitis and HTLV-I infection].
Mukae H; Higashiyama Y; Morikawa T; Kusano S; Morikawa N; Kadota J; Kohno S; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):17-24. PubMed ID: 8114368
[TBL] [Abstract][Full Text] [Related]
7. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.
Kadota J; Sakito O; Kohno S; Sawa H; Mukae H; Oda H; Kawakami K; Fukushima K; Hiratani K; Hara K
Am Rev Respir Dis; 1993 Jan; 147(1):153-9. PubMed ID: 8420410
[TBL] [Abstract][Full Text] [Related]
8. [Determination of the neutrophil chemotactic factor in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
Oda H; Kadota J; Sakito O; Mukae H; Morikawa N; Shukuwa C; Senju R; Sawa H; Kusano S; Morikawa T
Kansenshogaku Zasshi; 1992 Apr; 66(4):441-7. PubMed ID: 1624836
[TBL] [Abstract][Full Text] [Related]
9. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis.
Ashitani J; Mukae H; Nakazato M; Ihi T; Mashimoto H; Kadota J; Kohno S; Matsukura S
Eur Respir J; 1998 Jan; 11(1):104-11. PubMed ID: 9543278
[TBL] [Abstract][Full Text] [Related]
10. [A study of defensins in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
Mukae H; Ashitani J; Nakazato M; Taniguchi H; Date Y; Ihi T; Shiomi K; Mashimoto H; Kadota J; Kohno S
Kansenshogaku Zasshi; 1995 Sep; 69(9):975-81. PubMed ID: 7594798
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.
Ichikawa Y; Ninomiya H; Koga H; Tanaka M; Kinoshita M; Tokunaga N; Yano T; Oizumi K
Am Rev Respir Dis; 1992 Jul; 146(1):196-203. PubMed ID: 1626803
[TBL] [Abstract][Full Text] [Related]
12. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).
Kadota J; Matsubara Y; Ishimatsu Y; Ashida M; Abe K; Shirai R; Iida K; Kawakami K; Taniguchi H; Fujii T; Kaseda M; Kawamoto S; Kohno S
Clin Exp Immunol; 1996 Mar; 103(3):461-6. PubMed ID: 8608647
[TBL] [Abstract][Full Text] [Related]
13. Role of carbohydrate antigens sialyl Lewis (a) (CA19-9) in bronchoalveolar lavage in patients with pulmonary fibrosis.
Obayashi Y; Fujita J; Nishiyama T; Yoshinouchi T; Kamei T; Yamadori I; Hojo S; Ohtsuki Y; Hirashima M; Takahara J
Respiration; 2000; 67(2):146-52. PubMed ID: 10773785
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of sialyl SSEA-1 (SLX) in patients with idiopathic interstitial pneumonia].
Totani Y; Demura Y; Ameshima S; Miyamori I; Ishizaki T
Nihon Kokyuki Gakkai Zasshi; 2001 Apr; 39(4):238-43. PubMed ID: 11481821
[TBL] [Abstract][Full Text] [Related]
15. [CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia].
Shiota Y; Furuya K; Kitade M; Ueda N
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Aug; 27(8):887-93. PubMed ID: 2615104
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy.
Sakito O; Kadota J; Kohno S; Abe K; Shirai R; Hara K
Respiration; 1996; 63(1):42-8. PubMed ID: 8833992
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1995 Jul; 108(1):116-22. PubMed ID: 7606944
[TBL] [Abstract][Full Text] [Related]
18. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil chemotactic activity in bronchoalveolar lavage fluid recovered from patients with diffuse panbronchiolitis.
Katsuki M
Kurume Med J; 1996; 43(4):279-87. PubMed ID: 9029897
[TBL] [Abstract][Full Text] [Related]
20. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin.
Kudoh S; Azuma A; Yamamoto M; Izumi T; Ando M
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1829-32. PubMed ID: 9620913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
